18 41. Wetzels JW, Merkx MA, de Haan AF, Koole R, Speksnijder CM. Maximum mouth opening and trismus in 143 patients treated for oral cancer: a 1-year prospective study. Head & neck. 2014;36(12):1754-1762. 42. Vissink A, Burlage FR, Spijkervet FKL, Jansma J, Coppes R. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):213-225. 43. Braam PM, Roesink JM, Raaijmakers CP, Busschers WB, Terhaard CH. Quality of life and salivary output in patients with headand-neck cancer five years after radiotherapy. Radiation oncology. 2007;2:3. 44. Hutcheson KA, Lewin JS, Barringer DA, et al. Late dysphagia after radiotherapybased treatment of head and neck cancer. Cancer. 2012;118(23):5793-5799. 45. Alterio D, Gerardi MA, Cella L, et al. Radiation-induced acute dysphagia : Prospective observational study on 42 head and neck cancer patients. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]. 2017;193(11):971-981. 46. Elgestad Stjernfeldt P, Sjogren P, Wardh I, Bostrom AM. Systematic review of measurement properties of methods for objectively assessing masticatory performance. Clinical and experimental dental research. 2018;5(1):76-104. 47. Vermaire JA, Weinberg FM, Raaijmakers CPJ, Verdonck-de Leeuw IM, Terhaard CHJ, Speksnijder CM. Reliability of the mixing ability test testing masticatory performance in patients with head and neck cancer and healthy controls. Journal of oral rehabilitation. 2020. 48. Patterson JM, Hildreth A, McColl E, Carding PN, Hamilton D, Wilson JA. The clinical application of the 100mL water swallow test in head and neck cancer. Oral oncology. 2011;47(3):180-184. 49. Nathadwarawala KM, Nicklin J, Wiles CM. A timed test of swallowing capacity for neurological patients. J Neurol Neurosurg Psychiatry. 1992;55(9):822-825. 50. Roesink JM, Moerland MA, Battermann JJ, Hordijk GJ, Terhaard CH. Qualitative dosevolume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiation Oncology Biol Phys. 2001;51(4):938–946. 51. Dijkema T, Raaijmakers CP, Ten Haken RK, et al. Parotid gland function after radiotherapy: the combined michigan and utrecht experience. International journal of radiation oncology, biology, physics. 2010;78(2):449-453. 52. Scholtes VA, Terwee CB, Poolman RW. What makes a measurement instrument valid and reliable? Injury. 2011;42(3):236240. 53. van der Veen J, Nuyts S. Can IntensityModulated-Radiotherapy Reduce Toxicity in Head and Neck Squamous Cell Carcinoma? Cancers. 2017;9(12):135. 54. Singer S, Arraras JI, Chie WC, et al. Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQH&N35: a methodological review. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2013;22(8):1927-1941. 55. Bjordal K, de Graeff A, Fayers PM, et al. A 12 country field study of the EORTC QLQC30 (version 3.0) and the head and neck cancer specific module (EORTC QLQH&N35) in head and neck patients. EORTC Quality of Life Group. European journal of cancer. 2000;36(14):1796-1807. 56. Singer S, Araujo C, Arraras JI, et al. Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III. Head & Neck. 2014. 57. Bogaardt HC, Speyer R, Baijens LW, Fokkens WJ. Cross-cultural adaptation and validation of the Dutch version of SWALQoL. Dysphagia. 2009;24(1):66-70. 58. Rinkel RN, Verdonck-de Leeuw IM, Langendijk JA, van Reij EJ, Aaronson NK, Leemans CR. The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral oncology. 2009;45(8):e67-71. 59. Beetz I, Burlage FR, Bijl HP, et al. The Groningen Radiotherapy-Induced Xerostomia questionnaire: development and validation of a new questionnaire. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2010;97(1):127131.